Promising asthma trial prompts Regeneron, Sanofi to push dupilumab into PhIII – FierceBiotech


Reuters

Promising asthma trial prompts Regeneron, Sanofi to push dupilumab into PhIII
FierceBiotech
Regeneron and its close partner Sanofi have cleared the final mid-stage hurdle for dupilumab in asthma patients, with several doses hitting the trial endpoint both for a subset of patients as well as the broad population. And the ambitious development
Sanofi's dual-action biotech asthma drug performs well in testReuters
Positive results for Sanofi/Regeneron's dupilumab in asthmaThe Pharma Letter

all 29 news articles »

View full post on asthma – Google News

Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial] – 2 Minute Medicine


2 Minute Medicine

Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]
2 Minute Medicine
1. The rate of asthma exacerbations was significantly reduced in patients with severe eosphinophilic asthma receiving either intravenous or subcutaneous mepolizumab, compared to patients receiving placebo. 2. The safety profile of mepolizumab was
Seven developments in asthma researchHealio

all 2 news articles »

View full post on asthma – Google News

Nemours research trial aims to improve asthma treatment – WJXT Jacksonville


WJXT Jacksonville

Nemours research trial aims to improve asthma treatment
WJXT Jacksonville
“In the beginning, it was 'What happens in an asthma attack?' like on the daily and nightly report things I have to do. … They ask you certain questions like, 'Have you had an asthma attack today? How many doses of your medicine have you taken

and more »

View full post on asthma – Google News

A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients

Condition:   Post-ERCP Acute Pancreatitis
Interventions:   Drug: Rectal Indomethacin;   Drug: Epinephrine
Sponsors:   Johns Hopkins University;   American Society for Gastrointestinal Endoscopy;   Asian Institute of Gastroenterology, India;   Postgraduate Institute of Medical Education and Research;   Apollo Gleneagles Hospitals, India
Not yet recruiting – verified April 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Improved Asthma Treatment For African-Americans: NIH Trial To Explore … – Medical Daily


Medical Daily

Improved Asthma Treatment For African-Americans: NIH Trial To Explore
Medical Daily
Today the National Institutes of Health released a proposed study seeking to improve asthma in a population suffering from it the most: African-Americans. They said that the trial will explore different drugs and genetic factors for treating the
New Trial to Improve Asthma Control in African-AmericansMonthly Prescribing Reference
New Trial to Study Asthma Drug Responses, Genetic Factors in African-AmericansGenomeWeb

all 5 news articles »

View full post on asthma – Google News